Priebe Wealth Holdings’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,595
Closed -$307K 70
2024
Q3
$307K Sell
10,595
-1,467
-12% -$42.8K 0.22% 43
2024
Q2
$337K Buy
12,062
+1,611
+15% +$44.4K 0.27% 37
2024
Q1
$290K Buy
10,451
+771
+8% +$21.4K 0.23% 40
2023
Q4
$279K Buy
+9,680
New +$293K 0.23% 48

Other funds holding PFE

Priebe Wealth Holdings's PFE Position: Q4 2024 in Review

Priebe Wealth Holdings sold out of Pfizer (PFE) in Q4 2024, closing a stake of 10,595 shares — an estimated $307K sold.

Priebe Wealth Holdings first reported a position in PFE in Q4 2023 and held it in 4 quarters. The position peaked at $337K in Q2 2024. 2,996 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Priebe Wealth Holdings reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Priebe Wealth Holdings sold 10,595 Pfizer shares in Q4 2024, an estimated $307K.
  • Priebe Wealth Holdings first reported a position in Pfizer in Q4 2023 and held it in 4 quarters.
  • Priebe Wealth Holdings's Pfizer position peaked at $337K in Q2 2024.
  • 2,996 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Priebe Wealth Holdings's 13F filing for Q4 2024, filed 16 Jan 2025.